KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
KDIGO has noted the publication of the Systolic Blood Pressure Intervention Trial (SPRINT) results and has launched a process to review these and other new data to determine if revisions to its Blood Pressure Guideline are required. Clinicians who read the guideline should also refer to the SPRINT trial results available here.
In citing this document, the following format should be used: Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney inter., Suppl. 2012; 2: 337-414.
- Canadian Society of Nephrology
Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD
KDIGO is pleased to be able to provide the Guideline Executive Summary (Recommendation Statements only) in the following languages:
We would like to express our appreciation to all who contributed to the translation of the Blood Pressure in CKD Guideline.
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.